Overview

A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-11-13
Target enrollment:
Participant gender:
Summary
The main objective of the study is to assess the relative bioavailability of KAI-9531 subcutaneous (SC) injection in the upper arm and thigh compared to the abdomen.
Phase:
PHASE1
Details
Lead Sponsor:
Kailera